The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Anupa Mandava
No Relationships to Disclose
 
Ansy Patel
No Relationships to Disclose
 
Dean Pavlick
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Ole Gjoerup
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
Travel, Accommodations, Expenses - Foundation Medicine
 
Petros Grivas
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Daiichi Sankyo; EMD Serono; Foundation Medicine; Gilead Sciences; Janssen; Lilly; Merck; Pfizer; Replimune; Roche; Strata Oncology; Tyra Biosciences; Urogen pharma
Research Funding - Acrivon Therapeutics (Inst); ALX Oncology (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Genentech (Inst); Gilead Sciences (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Gilead Sciences
 
Sumanta Pal
Speakers' Bureau - IntrinsiQ; MJH Life Sciences; Peerview
Research Funding - Adicet Bio (Inst); Adicet Bio (Inst); ArsenalBio (Inst); crispr therapeutics (Inst); Exelixis (Inst); Genentech (Inst); Merck (Inst); Miyarisan pharmaceutical (Inst); Osel (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - crispr therapeutics; Exelixis; Ipsen
 
Neeraj Agarwal
Research Funding - Amgen (Inst); Arvinas (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celldex (Inst); crispr therapeutics (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); Gilead Sciences (Inst); Immunomedics (Inst); Janssen (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); ORIC Pharmaceuticals (Inst); ORIC Pharmaceuticals (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Exelixis; Pfizer
 
Shilpa Gupta
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb/Medarex; Foundation Medicine; Johnson & Johnson/Janssen; Merck; Natera; Novartis; Pfizer
Research Funding - Acrivon Therapeutics (Inst); Amgen (Inst); Bristol Myers Squibb Foundation (Inst); Convergent Therapeutics (Inst); Exelixis (Inst); Flare Therapeutics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Tyra Biosciences (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate author royalty
Travel, Accommodations, Expenses - Astellas Pharma; Merck; Pfizer
 
Roger Li
Stock and Other Ownership Interests - Beam Therapeutics; CRISPR therapeutics; Intellia Therapeutics; Lilly
Honoraria - IBCG; MashupMD; UroToday
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; CG Oncology; enGene; Ferring; ImmunityBio; Johnson & Johnson/Janssen; Merck; Pfizer; Photocure; Urogen pharma; Valar Labs
Speakers' Bureau - Johnson & Johnson/Janssen
Research Funding - CG Oncology; Predicine; Valar Labs
Travel, Accommodations, Expenses - CG Oncology; Predicine
Other Relationship - Predicine
 
Ashish Kamat
Leadership - American Urological Association; International Bladder Cancer Group (IBCG); World Bladder Cancer Patient Coalition
Consulting or Advisory Role - Aspira Women's Health (I); Astellas Pharma; Atonco Pharma; Biological Dynamics; Bristol-Myers Squibb; CG Oncology; Cystotech; Eisai; enGene; Ferring; Genentech; Imagin Medical; ImmunityBio; Imvax; Incyte; Janssen; Medac; Merck; Nonagen Bioscience; Pfizer; Photocure; Protara Therapeutics; Roche; Seagen; Sesen Bio; Theralase; Urogen pharma; US Biotest; Valar Labs; Vivet Therapeutics
Research Funding - Arquer Diagnostics (Inst); enGene (Inst); FKD Therapies (Inst); Patient-Centered Outcomes Research Institute (PCORI) (Inst); Photocure (Inst); Seagen (Inst); SWOG (Inst)
Patents, Royalties, Other Intellectual Property - Patent: CyPRIT (Cytokine Predictors of Response to Intravesical Therapy) joint with UT MD Anderson Cancer Center
Other Relationship - European Urology Oncology; Journal of Urology; UroToday
 
Joseph Jacob
Consulting or Advisory Role - Aura Biosciences; Janssen; Pfizer
 
Liang Cheng
Consulting or Advisory Role - Oxon
 
Douglas Lin
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche Pharma AG
 
Hanan Goldberg
Consulting or Advisory Role - Bayer; Myovant Sciences
Speakers' Bureau - Bayer; Pfizer; Telix Pharmaceuticals
Travel, Accommodations, Expenses - Teleflex Medical
 
Andrea Necchi
Employment - Bayer (I)
Stock and Other Ownership Interests - Bayer (I)
Consulting or Advisory Role - AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Catalym; Genenta Science; Gilead Sciences; Incyte; Johnson & Johnson/Janssen; Merck Serono; Merck Sharp & Dohme; Peerview; PeerVoice; Samsung Bioepis; Seattle Genetics/Astellas
Research Funding - Bristol-Myers Squibb/Celgene (Inst); Gilead Sciences (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Janssen; Merck Sharp & Dohme
 
Gennady Bratslavsky
Employment - AptaMatrix
Leadership - Ilgen; Taurus Diagnostics
Stock and Other Ownership Interests - Ilgen; Taurus Diagnostics
Consulting or Advisory Role - Johnson & Johnson/Janssen; Novartis
 
Philippe Spiess
Leadership - Global Society of Rare Genitourinary Tumors; NCCN; President of Global Society of Rare GU Tumors; Société Internationale d’Urologie Journal
Honoraria - UptoDate
Other Relationship - NCCN
(OPTIONAL) Uncompensated Relationships - Moffitt Cancer Center
 
Jeffrey Ross
Employment - Foundation Medicine
Leadership - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
Consulting or Advisory Role - Tango Therapeutics
Research Funding - Foundation Medicine
 
Alina Basnet
No Relationships to Disclose